14 results on '"Fabretti, Fabrizio"'
Search Results
2. Efficacy and adverse events profile of videolaryngoscopy in critically ill patients: subanalysis of the INTUBE study
- Author
-
Anstey, Matthew, Colica, Sandra, Brewster, David, Simpson, Shannon, Regli, Adrian, O'Grady, Ross, Litton, Edward, Ferrier, Janet, Bartholdy, Roland, Tabah, Alexis, Bowen, David, Rowley, Rebecca, Gatward, Jonathan, Alonso, Julio, Varkey, Sneha, Palaniswamy, Vijayanand, Chimunda, Timothy, Reza, Syed T., Hossain, Mozaffer, Islam, Motiul, Hamid, Tarikul, Parotto, Matteo, Ajami, Samareh, Steel, Andrew, Del Sorbo, Lorenzo, Goffi, Alberto, Randall, Ian, Adhikari, Neill K.J., Mehesry, Tasneem H., Vera, Maria M., Bugedo, Guillermo, Labarca, Gonzalo, Silva, Monica, Ma, Wuhua, Li, Yongxing, Wu, Jiayan, Wu, Lun, Radivojević, Renata Curić, Matas, Marijana, Ivančan, Višnja, Pavlek, Mario, Mihaljević, Slobodan, Jumić, Aleksandra, Moguš, Mate, Tucić, Iva, Michalek, Pavel, Flaksa, Marek, Aguirre-Bermeo, Hernan, Tirape-Castro, Hugo, García Aguilera, Maria F., Montenegro, Diana Alvarez, Tutillo, Diego Morocho, Tutillo León, Jose A., Winiszewski, Hadrien, Piton, Gael, Aissaoui, Nadia, Augy, Jean-Loup, Champigneulle, Benoit, Zlotnik, Diane, Muller, Grégoire, Jacquier, Sophie, Hraiech, Sami, Guervilly, Christophe, Plantefeve, Gaetan, Contou, Damien, Ricard, Jean Damien, Besset, Sebastien, Colin, Gwenhael, Pouplet, Caroline, Mirouse, Adrien, Azoulay, Elie, Boissier, Florence, Frat, Jean-Pierre, Mercier, Emmanuelle, Salmon-Gandonnière, Charlotte, Lascarrou, Jean-Baptiste, Martin, Maelle, Ferre, Alexis, Legriel, Stephane, Bruel, Cedric, Philippard, Francois, Zarka, Jonathan, Chemouni, Frank, Hamzaoui, Olfa, Sztrymf, Benjamin, Brunin, Yannick, Pili-Floury, Sébastien, Constantin, Jean-Michel, Godet, Thomas, Maraffi, Tommaso, Dessap, Armand Mekontso, Jozwiak, Mathieu, Marin, Nathalie, Guitton, Christophe, Chudeau, Nicolas, Gros, Alexandre, Boyer, Alexandre, Papandreou, Eleni, Petsiou, Athanasia, Papanikolaou, Metaxia, Kyparissi, Aikaterini, Tileli, Maria, Makris, Alexandros, Tsiftsis, Dimitrios, El-Fellah, Nadia, Karametos, Ilias, Nakou, Evi, Chalkias, Athanasios, Arnaoutoglou, Eleni, Katsoulis, Panagiotis, Pouriki, Sofia, Vagdatli, Kyriaki, Dimitropoulou, Aikaterini, Kothekar, Amol, Baliga, Nishanth, Korula, Sara V., Philip, Sam, Singh, Lalit, Agrawal, Nipun, Jeswani, Deepak, Jeswani, Deepti, Jha, Simant, Singh, Nitesh, Bhattacharyya, Mahuya, Das, Amit, Kuragayala, Swarna D., Kesavarapu, Subba R., Shah, Bhagyesh, Kaushik, Shuchi, Sunil, Nilu, Gnanadurai, Kingsly, Singh, Atul K., Singh, Dinesh K., Khunteta, Sudhir, Gupta, Kulbhusahn, Sanyal, Rhik, Midya, Abhirup, Tyagi, Vijay N., Bendre, Prashant, Prashant, Kumar, Chaurasia, Satish, Mishra, Prasanna, Dash, Sampat, Sundrani, Omprakash, Lalwani, Jaya, Jain, Nikhilesh, Agrawal, Kehari, Ray, Banambar, Meher, Ranjan, Saravanabavan, Lakshmikanthcharan, Munusamy, Satheesh, Gupta, Manish, Ahmad, Meraj, Gopalakrishna, Kadarapura N., Suparna, Bharadwaj, Surath, Manimala R., Munta, Kartik, Jagiasi, Bharat, Srivastava, Anand, Sahu, Samir, Mrinal, Sircar, Kumar, Singh Sujeet, Shah, Mehul, Patel, Mayur, Bamane, Shrirang, Narkhede, Amit, Chawla, Rajesh, Chawla, Aakanksha, Maheshwarappa, Harish Mallapura, Manjunath, Ramya Ballekatte, Rahmani, Lua, Laffey, John G., Rona, Roberto, Benini, Annalisa, Russotto, Vincenzo, Rundo, Annalisa, Luzi, Annalisa, Esposito, Clelia, Nespoli, Moana R., Pradella, Andrea, Lungu, Ramona, Baccari, Laura, Chiumiento, Fernando, Mariano, Karim, Cotoia, Antonella, De Rosa, Silvia, Boni, Elisa, Palmese, Salvatore, Gammaldi, Renato, Spadaro, Savino, Santoro, Lida, Cracchiolo, Andrea N., Palma, Daniela M., Pinciroli, Riccardo, Giovannini, Ilaria, Calamai, Italo, Spina, Rosario, Cappellini, Iacopo, Tutino, Lorenzo, Bellissima, Agrippino, Maugeri, Jessica G., Riva, Ivano, Fabretti, Fabrizio, Brazzi, Luca, Sales, Gabriele, Montrucchio, Giorgia, Orsello, Alberto, Costamagna, Andrea, Canavosio, Federico G., Pelagalli, Lorella, Marcelli, Maria E., Cortegiani, Andrea, Tramarin, Jacopo, Musso, Stefania, Tarantino, Stefano, Di Giacinto, Ida, Licciardi, Anna L., Montini, Luca, De Pascale, Gennaro, Giacomucci, Angelo, Russo, Pierpaolo, Longhini, Federico, Garofalo, Eugenio, Ferluga, Massimo, Moro, Valeria, Cascella, Marco, Di Caprio, Barbara, Di Fenza, Raffaele, Nespoli, Francesca, Bassini, Ospedale E., Muttini, Stefano, Pezzi, Angelo, Elhadi, Muhammed, Ghula, Mohamed, Ahmed, Hazem Abdelkarem, Khaled, Ala, Elhadi, Ahmed, Alhadi, Abdulmueti, Mazlan, Mohd Z., Wan Hassan, Wan Mohd N., Hasan, Shahnaz, Jamaluddin, Muhamad F.H., Samat, Noryani Mohd, Ismail, Muhamad A., Alias, Anita, Hwa, Ngu Pei, Irtiza, Ismail Nahla, Khalidah, Hapiz, Kiok, Lee Chew, Nordin, Norbaniza Mohd, Wan Ismail, Wan N., Ali, Mohd N., Sánchez-Hurtado, Luis, Toledo-Salinas, Otoniel, Landaverde, Antonio, Sosa, Miguel A., Gonzalez, Mayra Martinez, Lopez Nava, Claudia L., San Juan Roman, Nandyelly, Gonzalez, Maria, Espinoza, Missael, González, Daira, Flores, Fernando, Pantoja Leal, Jesus N., Loza Gallardo, Luis R., Young, Paul, Mistry, Ravi, Browne, Alexander, Crone, Petra, Chandwani, Juhi, Hossein, Sazzad, Koul, Salman S., Aman, Rubina, Ali, Syed M., Akhtar, Shazia N., Jankowski, Milosz, Bielanski, Piotr, Mudyna, Wojciech, Franczyk, Pawel, Galkin, Piotr, Skowronski, Lukasz, Gaszynski, Tomasz, Piegat, Mariusz, Catorze, Nuno, Pinto, Marcia, Leonor, Tiago, Fernandes, Marco, Campos, Patricia, Aragão, Irene, Costa, Paulo F., Franco, Daniela G., Basto, Marta, Nogueira, Carla, Cunha, Rui P., Costa, Vasco, Lomivorotov, Vladimir, Nikitenko, Artem, Belsky, Vladislav, Furman, Mikhail, Magomedov, Marat, Baturova, Vera, Karelov, Alexey, Marova, Nadezhda, Almekhlafi, Ghaleb, Alghamdi, Adnan, Maseda, Emilio, Suarez de la Rica, Alejandro, Gonzalez, Jesus Flores, Ruiz, Miryam Pérez, Roca, Oriol, Santafe, Manel, Fernandez, Gemma Goma, Escudero-Acha, Patricia, González-Castro, Alejandro, Agvald-Öhman, Christina, Broman, Lina, Spangfors, Martin, Hannesdottir, Katrin, Persson, Elin, Rosell, Jon, Sperber, Jesper, Ohlsson, Annika, Von Seth, Magnus, Pedrotti, Niccolò, Wahlstrom, Carl, Meirik, Maria, Bandert, Anna, Krog, Ditte, Kuo, Lu-Cheng, Shin, Ming-Hann, Chien, Jung-Yien, Ku, Shih-Chi, Ruan, Sheng-Yuan, Huang, Chun-Kai, Yeh, Yu-Chang, Chao, Anne, Wang, Kuo-Chuan, Chiu, Ching-Tang, Lee, Chien-Chang, Chou, Nai-Kuan, Szakmany, Tamas, Jones, Benjamin, Jones, Laura, Della Torre, Valentina, Sinah, Ayush, Quayle, Alice, Cheetham, Olivia, Syed, Yadullah, Mensah, Kwabena, Edmunds, Christopher, Kaye, Callum T., Bauer, Philippe R., Odeyemi, Yewande E., Nates, Joseph, Laserna, Andres, Mosier, Jarrod, Hypes, Cameron, Gottesman, Eric, Mastroianni, Fiore, Fein, Daniel G., Zhao, Dawn, Fonseca Fuentes, Xavier E., Gallo de Moraes, Alice, Sandefur, Benjamin J., Khan, Akram, Matos, Dubier, Kaufman, David A., Lehr, Andrew, Bigatello, Luca, Bonney, Iwona, Lascarrou, Jean Baptiste, Tassistro, Elena, Antolini, Laura, Bauer, Philippe, Szułdrzyński, Konstanty, Camporota, Luigi, Putensen, Christian, Pelosi, Paolo, Sorbello, Massimiliano, Higgs, Andy, Greif, Robert, Grasselli, Giacomo, Valsecchi, Maria G., Fumagalli, Roberto, Foti, Giuseppe, Caironi, Pietro, Bellani, Giacomo, and Myatra, Sheila N.
- Published
- 2023
- Full Text
- View/download PDF
3. Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure
- Author
-
Damiani, Marianna, Gandini, Lucia, Landi, Francesco, Borleri, Gianmaria, Fabretti, Fabrizio, Gritti, Giuseppe, and Riva, Ivano
- Published
- 2021
- Full Text
- View/download PDF
4. Coagulopathy and COVID-19
- Author
-
Lorini, Ferdinando Luca, primary, Di Matteo, Maria, additional, Gritti, Paolo, additional, Grazioli, Lorenzo, additional, Benigni, Alberto, additional, Zacchetti, Lucia, additional, Bianchi, Isabella, additional, Fabretti, Fabrizio, additional, and Longhi, Luca, additional
- Published
- 2021
- Full Text
- View/download PDF
5. Worsening of gas exchange parameters at high FiO2 in COVID-19: misleading or informative?
- Author
-
Raimondi, Federico, primary, Novelli, Luca, additional, Marchesi, Gianmariano, additional, Riva, Ivano, additional, Grazioli, Lorenzo Stephan, additional, Allegri, Chiara, additional, Biza, Roberta, additional, Trapasso, Roberta, additional, Amoroso, Mariangela, additional, Anelli, Marisa, additional, Galimberti, Chiara, additional, Fabretti, Fabrizio, additional, Lorini, Ferdinando Luca, additional, and Di Marco, Fabiano, additional
- Published
- 2021
- Full Text
- View/download PDF
6. Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19
- Author
-
Peri, Anna Maria, primary, Magro, Bianca, additional, van den Bogaart, Lorena, additional, dalla Pria, Alessia, additional, Giuffrida, Paolo, additional, Gianatti, Andrea, additional, Fabretti, Fabrizio, additional, Maria Barbui, Anna, additional, Tebaldi, Alessandra, additional, Rizzi, Marco, additional, and Fagiuoli, and Stefano, additional
- Published
- 2021
- Full Text
- View/download PDF
7. Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
- Author
-
Gritti, Giuseppe, Raimondi, Federico, Ripamonti, Diego, Riva, Ivano, Landi, Francesco, Alborghetti, Leonardo, Frigeni, Marco, Damiani, Marianna, Micò, Caterina, Fagiuoli, Stefano, Cosentini, Roberto, Luca Lorini, Ferdinando, Fabretti, Fabrizio, Morgan, Jonathan, Owens, Benjamin M.J., Kanhai, Karan, Cowburn, Jim, Tonkovivic Reljanovic, Gordana, Rizzi, Marco, Di Marco, Fabiano, and Rambaldi, Alessandro
- Abstract
COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SAR-CoV-2), resulting in symptoms, such as fever, cough, and shortness of breath. The SARS-CoV-2 virus has also been suggested to initiate a cytokine storm in patients with COVID-19 evidenced by elevated cytokines, such as interleukin-6 (IL-6) and C-reactive protein (CRP). We report preliminary data from 21 patients with COVID-19 who developed pneumonia/acute respiratory distress syndrome (ARDS) and participated in a compassionate-use program at Papa Giovanni XXIII hospital in Bergamo, Italy. All 21 patients received intravenous siltuximab, a chimeric mAb that binds to and blocks the effect of IL-6, at a dose ranging between 700 to 1,200 mg (median 900 mg). The median age of patients treated was 64 years, and all patients were followed for a median of eight days. Serum CRP levels reduced in all 16 patients with available data following treatment. An improvement in the clinical condition was observed in 33% (7/21) of patients, 43% (9/21) of patients stabilized as evidenced by no clinically relevant change in their condition, and 24% (5/21) experienced a worsening in their condition. Of those patients who experienced a worsening in their condition, one patient died, and one patient experienced a cerebrovascular event. This analysis is presented to inform the medical community of the potential role of siltuximab in treating patients with ARDS secondary to SARS-CoV-2 infection, and a cohort study with patients treated with standard therapy in our hospital is ongoing, and will report the 30-day mortality rates upon completion.
- Published
- 2020
- Full Text
- View/download PDF
8. COVID‐19 provoking Guillain–Barré syndrome: The Bergamo case series
- Author
-
Foresti, Camillo, primary, Servalli, Maria Cristina, additional, Frigeni, Barbara, additional, Rifino, Nicola, additional, Storti, Benedetta, additional, Gritti, Paolo, additional, Fabretti, Fabrizio, additional, Grazioli, Lorenzo, additional, and Sessa, Maria, additional
- Published
- 2020
- Full Text
- View/download PDF
9. Potential role of subcutaneous tocilizumab injections in patients with COVID‐19 associated pneumonia
- Author
-
Greco, Giuseppe, primary, Ripamonti, Diego, additional, Binda, Francesca, additional, Fabretti, Fabrizio, additional, Grazioli, Lorenzo, additional, and Rizzi, Marco, additional
- Published
- 2020
- Full Text
- View/download PDF
10. Extracorporeal Cytokine Hemadsorption in Severe COVID-19 Respiratory Failure
- Author
-
Damiani, Marianna, primary, Gandini, Lucia, additional, Landi, Francesco, additional, Fabretti, Fabrizio, additional, Gritti, Giuseppe, additional, and Riva, Ivano, additional
- Published
- 2020
- Full Text
- View/download PDF
11. Papa Giovanni XXIII Bergamo Hospital at the time of the COVID‐19 outbreak: Letter from the warfront…
- Author
-
Buoro, Sabrina, primary, Di Marco, Fabiano, additional, Rizzi, Marco, additional, Fabretti, Fabrizio, additional, Lorini, Ferdinando Luca, additional, Cesa, Simonetta, additional, and Fagiuoli, Stefano, additional
- Published
- 2020
- Full Text
- View/download PDF
12. Worsening of gas exchange parameters at high FiO2 in COVID-19: misleading or informative?
- Author
-
Raimondi, Federico, Novelli, Luca, Marchesi, Gianmariano, Fabretti, Fabrizio, Grazioli, Lorenzo, Riva, Ivano, Allegri, Chiara, Biza, Roberta, Galimberti, Chiara, Lorini, Ferdinando Luca, and Di Marco, Fabiano
- Subjects
TYPE 2 diabetes ,COVID-19 ,RESPIRATORY insufficiency - Abstract
Background: In COVID-19, higher than expected level of intrapulmonary shunt has been described, in association with a discrepancy between the initial relatively preserved lung mechanics and the hypoxia severity. This study aim was to measure the shunt fraction and variations of PaO2/FiO2 ratio and oxygen alveolar-arterial gradient (A-a O2) at different FiO2. Methods: Shunt was measured by a non-invasive system during spontaneous breathing in 12 patients hospitalized at COVID-19 Semi-Intensive Care Unit of Papa Giovanni XXIII Hospital, Bergamo, Italy, between October 22 and November 23, 2020. Results: Nine patients were men, mean age (±SD) 62±15 years, mean BMI 27.5±4.8 Kg/m2. Systemic hypertension, diabetes type 2 and previous myocardial infraction were referred in 33%, 17%, and 7%, respectively. Mean PaO2/FiO2 ratio was 234±66 and 11 patients presented a bilateral chest X-ray involvement. Mean shunt was 21±6%. Mainly in patients with a more severe respiratory failure, we found a progressive decrease of PaO2/FiO2 ratio with higher FiO2. Considering (A-a O2), we found a uniform tendency to increase with FiO2 increasing. Even in this case, the more severe were the patients, the higher was the slope, suggesting FiO2 insensitiveness due to a shunt effect, as strengthened by our measurements. Conclusion: Relying on a single evaluation of PaO2/FiO2 ratio, especially at high FiO2, could be misleading in COVID-19. We propose a two steps evaluation, the first at low SpO2 value (e.g., 92-94%) and the second one at high FiO2 (i.e., >0.7), allowing to characterize both the amendable (ventilation/perfusion mismatch), and the fixed (shunt) contribution quote of respiratory impairment, respectively. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Potential role of subcutaneous tocilizumab injections in patients with COVID‐19 associated pneumonia.
- Author
-
Greco, Giuseppe, Ripamonti, Diego, Binda, Francesca, Fabretti, Fabrizio, Grazioli, Lorenzo, and Rizzi, Marco
- Subjects
COVID-19 ,SUBCUTANEOUS injections ,SARS-CoV-2 - Abstract
Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia Guaraldi et al.1 found a significant reduction in risk of invasive mechanical ventilation or death in patients with severe coronavirus disease 2019 (COVID-19) pneumonia who were treated with either I.V. or S.C. tocilizumab and standard of care, compared with those treated with standard of care only. Eleven (45.8%) had AST/ALT increases (<400 IU/L, but for one intensive care unit patient with multiorgan failure who had 4900/5100 U/L), four patients had thrombocytopenia (all higher than 55 × 10 SP 9 sp /L), three had mild neutropenia (all higher than 800 cells/mm SP 3 sp ). [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
14. COVID‐19 provoking Guillain–Barré syndrome: The Bergamo case series.
- Author
-
Foresti, Camillo, Servalli, Maria Cristina, Frigeni, Barbara, Rifino, Nicola, Storti, Benedetta, Gritti, Paolo, Fabretti, Fabrizio, Grazioli, Lorenzo, and Sessa, Maria
- Subjects
GUILLAIN-Barre syndrome ,COVID-19 ,POLYNEUROPATHIES ,LOW-molecular-weight heparin - Abstract
COVID-19 provoking Guillain-Barré syndrome: The Bergamo case series Keywords: COVID-19; critical illness; Guillain-Barré syndrome; mechanical ventilation EN COVID-19 critical illness Guillain-Barré syndrome mechanical ventilation e84 e85 2 09/17/21 20211001 NES 211001 ACKNOWLEDGEMENTS No funding was obtained for the present study. Amongst 1832 COVID-19 patients hospitalized between 23 February and 21 May, we diagnosed 17 cases of Guillain-Barré syndrome (GBS). [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.